Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MKS transition zone complex subunit 1 (MKS1) is a protein localized to the basal body and transition zone of the primary cilium in eukaryotic cells[1][2][7]. MKS1 is essential for the biogenesis and structural maintenance of the primary cilium, a microtubule-based organelle involved in signaling and development[1][3]. MKS1 is a core component of the Meckel-Gruber syndrome (MKS) module, a multi-protein complex at the ciliary transition zone that functions as a gating structure, regulating protein and lipid movement into the cilium and facilitating the docking of the basal body to the plasma membrane[1][5]. Mutations in the MKS1 gene cause Meckel syndrome (a lethal congenital ciliopathy with CNS, renal, and hepatic malformations) and Bardet-Biedl syndrome (a multisystem disorder), demonstrating MKS1’s key role in mammalian development and signaling[1][2][3][4][5][7]. MKS1 also interacts functionally with the BBSome and intraflagellar transport (IFT) complexes, coordinating trafficking of signaling molecules such as transmembrane receptors to the cilium, and supporting Hedgehog pathway signaling[4][5]. Complete disruption of MKS1 leads to loss of cilia formation and severe developmental abnormalities[1][2][3][5]. Currently, no approved therapeutic drugs target MKS1 directly, but its gene and protein functions are exploited as biomarkers for diagnosing and understanding ciliopathies[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MKS transition zone complex subunit 1 (MKS1).